Genpact, AstraZeneca Extend Finance and Accounting Services Agreement

Genpact Limited (NYSE: G ) today announced a multi-year contract extension for its global finance and accounting (F&A) services agreement with leading pharmaceutical company AstraZeneca (NYSE: AZN ) The AstraZeneca-Genpact relationship launched in 2009. Through its unique Smart Enterprise Processes (SEPSM) methodology for improving the effectiveness of business processes,